Deutsche Bank Ag\ Bridge Bio Pharma, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 297,081 shares of BBIO stock, worth $8.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

297,081

Previous 278,231 6.77%

Holding current value

$8.64 Million

Previous $7.05 Million 7.32%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$23.91 - $31.3 $450,703 - $590,005	18,850 Added 6.77%	297,081 $7.56 Million
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $1.2 Million - $1.61 Million	-51,978 Reduced 15.74%	278,231 $7.05 Million
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $2.3 Million - $3.4 Million	84,156 Added 34.2%	330,209 $10.2 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $1.08 Million - $1.97 Million	44,777 Added 22.25%	246,053 $9.93 Million
Q3 2023 Nov 09, 2023	SELL	$16.89 - $35.01 $1.2 Million - $2.49 Million	-71,001 Reduced 26.08%	201,276 $5.31 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $1.54 Million - $2.09 Million	-115,809 Reduced 29.84%	272,277 $4.68 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $730,895 - $1.89 Million	101,938 Added 35.62%	388,086 $6.43 Million
Q4 2022 Feb 13, 2023	BUY	$6.74 - $11.52 $647,808 - $1.11 Million	96,114 Added 50.58%	286,148 $2.18 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $652,183 - $1.02 Million	82,139 Added 76.13%	190,034 $1.89 Million
Q2 2022 Aug 11, 2022	BUY	$5.21 - $12.14 $222,618 - $518,730	42,729 Added 65.57%	107,895 $979,000
Q1 2022 May 13, 2022	SELL	$7.34 - $17.16 $32,464 - $75,898	-4,423 Reduced 6.36%	65,166 $662,000
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $167,536 - $786,302	-14,722 Reduced 17.46%	69,589 $1.16 Million
Q3 2021 Nov 04, 2021	SELL	$46.87 - $64.24 $11.4 Million - $15.6 Million	-242,751 Reduced 74.22%	84,311 $3.95 Million
Q2 2021 Aug 11, 2021	SELL	$46.47 - $63.93 $9.28 Million - $12.8 Million	-199,698 Reduced 37.91%	327,062 $19.9 Million
Q1 2021 May 13, 2021	BUY	$55.47 - $72.35 $26.2 Million - $34.2 Million	472,390 Added 868.84%	526,760 $32.4 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $559,772 - $1.04 Million	14,585 Added 36.66%	54,370 $3.87 Million
Q3 2020 Nov 12, 2020	SELL	$27.2 - $42.19 $59,051 - $91,594	-2,171 Reduced 5.17%	39,785 $1.49 Million
Q2 2020 Aug 13, 2020	BUY	$22.22 - $35.69 $353,364 - $567,578	15,903 Added 61.04%	41,956 $1.37 Million
Q1 2020 May 14, 2020	BUY	$16.11 - $36.23 $289,206 - $650,400	17,952 Added 221.6%	26,053 $755,000
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $28,269 - $73,395	1,574 Added 24.12%	8,101 $283,000
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $131,388 - $211,344	6,527 New	6,527 $138,000

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account